医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

The International Bio-Community Meets in Japan!Announcing Integrated Biotech Business Event – BioJapan 2014

2014年08月29日 AM09:00
このエントリーをはてなブックマークに追加


 

TOKYO

BioJapan 2014 – World Business Forum – will be held for three days from October 15th (Wed.) to 17th (Fri.), 2014 at Pacifico Yokohama (Exhibition Halls C & D, and Annex Hall).

BioJapan 2013 - Partnering Area - (Photo: Business Wire)

BioJapan 2013 – Partnering Area – (Photo: Business Wire)

Comprised of exhibition, seminars and business partnering, BioJapan is the largest biotechnology partnering event in Asia. The theme of 16th BioJapan is ‘Ever-Evolving Bio-Business’. As an integrated exhibition which includes regenerative medicine, personalized medicine, diagnostics, functional food, bio-energy and other biotechnology topics, top-level executives and persons responsible for R&D, business development, licensing and alliances gather under one roof at this event to share cutting-edge solutions, technology and information.

  • 6,000 business meetings! Approximately 700 global companies converge, including everyone from Big Pharma to bio-ventures
    In addition to the official sponsors, Chugai Pharmaceutical, Kyowa Hakko Kirin, MSD and Novartis Pharma, participants from over 30 foreign countries will take part in business meetings. Participants will include Big Pharma players such as Takeda Pharmaceutical, Astellas Pharma, Daiichi Sankyo, Mitsubishi Tanabe Pharma, AstraZeneca, Sanofi and Pfizer, as well as drug manufacturing SMEs, bio-ventures, research institutions and universities. Last year 204 companies attended from overseas – 2.3 times more than 2012! Do not miss BioJapan, an event that is rapidly increasing its presence in the global market.
    Check the URL below for a list of companies participating in the partnering. At the time of writing
    (Aug. 22nd), 443 companies have already registered!
    http://www.ics-expo.jp/biojapan/partnering_list.html
  • Professor Shinya Yamanaka (Kyoto University) is also scheduled to take the podium! Over 200 sponsor seminars and presentations from exhibitors will be held.
    This marks the return of Nobel prize-winning professor Shinya Yamanaka, who will make an appearance on the podium after a two-year absence. In addition to Prof. Yamanaka’s address on current research topics entitled ‘New Era of Medicine with iPS Cells’, there will be a wide array of seminars held regarding regenerative medicine.

[Keynote speakers] October 15th (Wed.) from 10:00 to 11:30

  • Hiroto Izumi (Special Advisor to the Prime Minister)
    “Realization of Healthy and Longevity Society by the Healthcare Policy”
  • Gladys H. Monroy (Senior Partner, Morrison & Foerster LLP), “Recent Supreme Court Decisions: The Effect on Obtaining and Enforcing Patents on Biological Products in the U.S.”
  • Masatoshi Ito (Representative Director, President & CEO, Ajinomoto Co., Inc.)
    “Growth Strategy of Unique Food Company Driven by Technology”

*Click here for more information.

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140828005021/en/

CONTACT

Secretariat of BioJapan:
c/o ICS Convention Design, Inc.
Maiko
Uchiyama, +81-3-3219-3565
biojapan@ics-inc.co.jp

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • AnHeart Therapeutics Announces Formation of Scientific Advisory Board
  • Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to Proceed into Phase 2 and Phase 3a for ARCT-154, Next Generation STARR™ mRNA Vaccine Targeting SARS-CoV-2 Delta Variant and Other Variants of Concern
  • Celltrion用于治疗COVID-19的单克隆抗体瑞丹维单抗(CT-P59)成为韩国食品药品安全部(MFDS)首个核准用于治疗COVID-19的药物
  • Celltrionのモノクローナル抗体治療薬、Regdanvimab(CT-P59)は、韓国食品医薬品安全庁(MFDS)からCOVID-19感染症治療薬として初めて承認された。
  • Fewer Australians report a sense of belonging at work when compared to pre-pandemic